SE351426B - - Google Patents

Info

Publication number
SE351426B
SE351426B SE06517/68A SE651768A SE351426B SE 351426 B SE351426 B SE 351426B SE 06517/68 A SE06517/68 A SE 06517/68A SE 651768 A SE651768 A SE 651768A SE 351426 B SE351426 B SE 351426B
Authority
SE
Sweden
Application number
SE06517/68A
Inventor
T Petrzilka
Original Assignee
T Petrzilka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Petrzilka filed Critical T Petrzilka
Publication of SE351426B publication Critical patent/SE351426B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE06517/68A 1967-05-19 1968-05-14 SE351426B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH708167A CH481911A (de) 1967-05-19 1967-05-19 Verfahren zur Herstellung von tricyclischen Verbindungen

Publications (1)

Publication Number Publication Date
SE351426B true SE351426B (cg-RX-API-DMAC10.html) 1972-11-27

Family

ID=4319634

Family Applications (1)

Application Number Title Priority Date Filing Date
SE06517/68A SE351426B (cg-RX-API-DMAC10.html) 1967-05-19 1968-05-14

Country Status (11)

Country Link
US (1) US3560528A (cg-RX-API-DMAC10.html)
AT (1) AT277241B (cg-RX-API-DMAC10.html)
BE (1) BE714766A (cg-RX-API-DMAC10.html)
CH (1) CH481911A (cg-RX-API-DMAC10.html)
DE (1) DE1768230A1 (cg-RX-API-DMAC10.html)
DK (1) DK125707B (cg-RX-API-DMAC10.html)
ES (1) ES354081A1 (cg-RX-API-DMAC10.html)
FR (1) FR1593512A (cg-RX-API-DMAC10.html)
GB (1) GB1152820A (cg-RX-API-DMAC10.html)
NL (1) NL6806383A (cg-RX-API-DMAC10.html)
SE (1) SE351426B (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025516A (en) * 1975-06-23 1977-05-24 The John C. Sheehan Institute For Research, Inc. Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans
US4054583A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Process for converting 2,7-dihydroxy-5-isopropylidene-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin to trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo(b,d)pyran-9-one
US4381399A (en) * 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
US7923558B2 (en) * 2004-07-19 2011-04-12 Cilag Ltd. Method for obtaining pure tetrahydrocannabinol
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US20170038184A1 (en) 2015-08-06 2017-02-09 Charles E. Ankner Formulation delivery system
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia

Also Published As

Publication number Publication date
GB1152820A (en) 1969-05-21
FR1593512A (cg-RX-API-DMAC10.html) 1970-06-01
CH481911A (de) 1969-11-30
BE714766A (cg-RX-API-DMAC10.html) 1968-11-07
DE1768230A1 (de) 1971-06-03
AT277241B (de) 1969-12-10
NL6806383A (cg-RX-API-DMAC10.html) 1968-11-20
ES354081A1 (es) 1969-10-16
DK125707B (da) 1973-03-26
US3560528A (en) 1971-02-02

Similar Documents

Publication Publication Date Title
FR1593512A (cg-RX-API-DMAC10.html)
BE707451A (cg-RX-API-DMAC10.html)
BE703860A (cg-RX-API-DMAC10.html)
BE710959A (cg-RX-API-DMAC10.html)
BE708691A (cg-RX-API-DMAC10.html)
BE702189A (cg-RX-API-DMAC10.html)
BE709870A (cg-RX-API-DMAC10.html)
BE711557A (cg-RX-API-DMAC10.html)
BE710894A (cg-RX-API-DMAC10.html)
BE711259A (cg-RX-API-DMAC10.html)
BE704953A (cg-RX-API-DMAC10.html)
BE709327A (cg-RX-API-DMAC10.html)
BE710886A (cg-RX-API-DMAC10.html)
BE709453A (cg-RX-API-DMAC10.html)
BE709254A (cg-RX-API-DMAC10.html)
BE704265A (cg-RX-API-DMAC10.html)
BE699802A (cg-RX-API-DMAC10.html)
BE710117A (cg-RX-API-DMAC10.html)
BE708638A (cg-RX-API-DMAC10.html)
BE701296A (cg-RX-API-DMAC10.html)
BE710613A (cg-RX-API-DMAC10.html)
BE708118A (cg-RX-API-DMAC10.html)
BE706535A (cg-RX-API-DMAC10.html)
BE709586A (cg-RX-API-DMAC10.html)
BE711116A (cg-RX-API-DMAC10.html)